← Protocol Reference
Recovery & healingField ref.
TB-500 Systemic Recovery Protocol
Broad soft-tissue and post-training recovery
Overview
Unlike BPC-157, TB-500 (a Thymosin Beta-4 fragment) is almost always dosed systemically rather than locally, since its proposed mechanism (actin regulation, cell migration) is framed as a body-wide effect rather than site-specific. Community protocols typically run a higher-dose "loading" phase before dropping to a lower maintenance dose.
Dosing schedule
Informational only — not medical advice.
| Phase | Amount | Frequency | Timing | Route |
|---|---|---|---|---|
| Loading — Weeks 1–4 | 2–2.5 mg | 2x/week | — | subcutaneous injection |
| Maintenance — Weeks 5+ | 2–2.5 mg | 1x/week | — | subcutaneous injection |
Administration
Reconstitute with bacteriostatic water; injection site is largely irrelevant given the proposed systemic mechanism (commonly abdominal subcutaneous). Refrigerate after reconstitution.
Cycle length
4 weeks on, 4 weeks off. A 4-week loading phase is typical before reassessing whether to continue into maintenance dosing.
Stacking
- BPC-157 — Complementary recovery mechanism; frequently run together.
Precautions
- Long-term human safety data is sparse — most literature is preclinical.
- Theoretical angiogenesis-related caution for anyone with a history of cancer.
- Discontinue on any signs of injection-site infection or allergic reaction.